Search for Merck KGaA and
  1. August 17, 2014

    Lanxess buoyed by Zachert’s return to take helm of group

    When Matthias Zachert announced in January that he would step down from his role as chief financial officer at Merck KGaA...

  2. May 7, 2014

    Lanxess to raise 10% more capital

    Lanxess is set to issue new shares equivalent to 10 per cent of its equity capital as new chief executive Matthias Zachert...

  1. February 9, 2014

    German drugmaker Merck steps up push into biosimilars

    Merck is stepping up its push into a new class of copycat medicines that offer hope of lower drugs bills for national...

  2. January 27, 2014

    Merck: teary farewell

    Chief financial officers are supposed to sweet-talk markets. That is their job. But is sweet talk worth a 10th of a...

  3. January 26, 2014

    Lanxess chief Heitmann to quit as profits fall

    Lanxess chief executive Axel Heitmann is to stand down after the speciality chemical company’s profits were hit by growing...

  4. December 6, 2013

    Letter from Lex: giving up investor fight

    Activist investors get a bad rap. Sometimes they deserve it, such as when famed US corporate raider Carl Icahn first stood...

  5. December 5, 2013

    Lynch backing augments the prospects for Neurence

    It is James Bond meets Harry Potter meets Arnie Schwarzenegger. And Mike Lynch meets them all. Don the glasses or point your...

  6. December 5, 2013

    Merck KGaA: chemical weapon

    Diversification, thy name is Merck. Since 2007, the German chemical and pharmaceutical group has been on a transformation...

  7. September 30, 2013

    Investors should seek to add ratios to new pay regime

    The friction between Tories and Liberal Democrats through the political conference season makes the harmony on display in...

  8. August 6, 2013

    Merck KGaA: drug screening

    Merck KGaA, as its corporate history says, has been offering “growth and transformation since 1668”. Even after 345 years,...

  9. July 28, 2013

    Loescher’s Siemens tenure looks tenuous

    When Peter Loescher was hired from Merck, the pharmaceuticals group, in 2007, the new Siemens chief executive moved...

  10. June 19, 2013

    Lundbeck fined €94m for ‘pay for delay’ deals to rivals

    European regulators have fined Lundbeck, the Danish pharmaceutical company, €94m for paying rivals to delay cut-price...

  11. May 28, 2013

    Pharma M&A: defensive deals

    Another day, another healthcare sector deal. AstraZeneca’s purchase of Omthera on Tuesday is small (maximum value: $443m),...

  12. May 22, 2013

    Metro rises after broker gets positive

    Metro was in high demand after the German retailer received a vote of confidence from Morgan Stanley analysts for the first...

  13. May 9, 2013

    Germany: for richer, for poorer

    Pity the poor Germans. Never mind that two Bundesliga teams are in the Champions League football final this month. Or that...

  14. March 11, 2013

    Skills for global business

    When Doug Baillie first walked into his Mumbai office as the chief executive of Hindustan Lever in 2006, he knew he would be...

  15. February 11, 2013

    Novo Nordisk ails after drug ruling

    News that Novo Nordisk , the Danish drugs company, failed to win approval for a new drug triggered a strong response from...

  16. December 6, 2012

    Contrasting fortunes for Germany and Italy

    German stocks hit a near five-year closing high on Thursday, while Italian stocks fell amid domestic political tensions, in...

  17. December 6, 2012

    Frankfurt stocks near 4-year high

    German stocks were edging up towards multiyear highs on Thursday, while Italian stocks fell sharply amid domestic political...

  18. November 28, 2012

    Outsourced drug trials lack oversight, study says

    Leading pharmaceuticals companies show no evidence that they adequately supervise the conduct of outsourced clinical drug...

  19. November 4, 2012

    Pharmas offer to cap cost of Greek medicine

    Leading pharmaceutical companies have offered to cap the total costs of medicines supplied to the Greek government, as they...

  20. November 3, 2012

    Merck halts cancer drug supply to Greek hospitals

    FRANKFURT, November 3 – Merck, the German pharmaceuticals group, is no longer delivering the cancer drug Erbitux to Greek...

  21. August 26, 2012

    Belt-tightening reaches heart of Germany

    Cost cutting and job losses are no longer confined to Europe’s indebted periphery. As the eurozone heads towards another...

  22. March 28, 2012

    Bertelsmann: going forward ... at last

    No offence to Gütersloh, but Bertelsmann looks ready to shed its small-town mentality. Chief executive Thomas Rabe has...

  23. March 28, 2012

    Bertelsmann moves closer to stake sale

    Bertelsmann has taken a step towards selling a strategic stake, or listing its shares on the stock market, moves that would...

  24. March 5, 2012

    European drugmakers

    Developing drugs can be all or nothing. To see how the sharp edge of that proposition feels, look at UCB and Merck. During...

  25. February 15, 2012

    European healthcare: Ailments encapsulated

    In the European Commission’s enterprise directorate in Brussels, offices have emptied in recent months as officials who once...

  26. February 5, 2012

    Pharma seeks to ease pain of euro crisis

    With Greece and Spain struggling to repay billions of euros in outstanding debts to the healthcare sector as the eurozone...

  27. December 30, 2011

    European banks suffer as crisis grows

    European equity markets had a largely unremarkable last week of 2011, but few investors were likely to forget this year,...

  28. December 5, 2011

    A model for healthier profits

    When Poul Rasmussen is asked to justify the unusual governance structure of Leo Pharma, the Danish pharmaceutical group, he...

  29. FT Alphaville

    October 26, 2011

    Snap news

    Breaking pre-market news on Wednesday, - Lehman’s joint chapter 11 plan gets support from creditors holding over $160bn in...

  30. July 31, 2011

    Inventories: the bullwhip effect

    Producers of almost everything were left stranded when the global downturn took hold and retailers ran down inventories. On...

  31. July 27, 2011

    Merck: writedowns fail to dim prospects

    Investors expect new management to downplay a company’s prospects and write down assets. Frans van Houten, chief executive...

  32. July 27, 2011

    Merck reports operating loss of €11m

    Merck reduced profits guidance for the year as it posted second-quarter losses worse than expectations, driven by...

  33. July 17, 2011

    The job: Corporate orchestra manager

    Stefan Reinhardt, Merck In the 19th century there was an orchestra for Merck employees, which was restarted in Germany in...

  34. May 19, 2011

    Thermo Fisher to pay €2.47bn for Phadia

    Thermo Fisher, the US medical equipment company, has agreed to buy Phadia, an allergy diagnosis company, from private equity...

  35. May 19, 2011

    US and Europe escape worst of quake’s aftershock

    US and European companies have generally suffered only minor and short-lived disruption as a result of the March 11...

  36. March 28, 2011

    Actelion fights back over Elliott campaign

    Actelion, the Swiss biotech group being stalked by Elliott Advisors on Monday accused the leading hedge fund of lacking a...

  37. March 17, 2011

    Elliott proposes Actelion board members

    Elliott Advisers, the US-based hedge fund stalking Actelion, on Thursday put forward its own candidates for the board of...

  38. February 21, 2011

    Millipore acquisition helps boost Merck

    The acquisition of Millipore helped Merck KGaA of Germany sharply lift full-year profits beyond expectations even as...

Search for Merck KGaA and